The Effects of an ER Beta Agonist (Lilly Compound LY500307) on Estradiol-withdrawal-induced Mood Symptoms in Women With Past Perimenopausal Depression
Phase of Trial: Phase II
Latest Information Update: 17 Aug 2019
Price : $35 *
At a glance
- Drugs Erteberel (Primary) ; Estradiol
- Indications Depression
- Focus Therapeutic Use
- 13 Aug 2019 Planned End Date changed from 31 Dec 2022 to 30 Sep 2024.
- 23 May 2019 Planned initiation date (estimated date for recruitment of the first subject) changed from 1 May 2019 to 29 May 2019.
- 25 Apr 2019 Planned initiation date (estimated date for recruitment of the first subject) changed from 30 april 2019 to 1 may 2019.